FDA Approves Twice-Yearly Injectable to Prevent HIV
The FDA has approved a first ever twice-yearly injectable regimen for HIV prevention in adults and adolescents, offering an effective alternative to daily PrEP.
More Videos
How The Brooklyn Army Terminal Became NYC's $100 Million Climate Hub
NYC just invested $100 million to turn a historic military base into a climate tech proving ground. We went inside the Brooklyn Army Terminal to find out why.
Why AI Companies May Soon Be Sharing Their Most Powerful Models With the Government
Politico's Cheyenne Haslett breaks down Trump's new AI executive order, the AI race with China, industry reaction, and what's next for regulation.
Inside the Aerospace IPO Positioning for the Next Decade of Defense Growth
Applied Aerospace & Defense CEO Trip Ferguson discusses the company's IPO, defense spending, space innovation, and the future of U.S. aerospace manufacturing.
How Crunch Fitness Is Redefining Your Exercise Routine
Jim Rowley, CEO of Crunch Fitness, discusses affordable fitness, industry growth, and why value-focused gyms continue to attract members.
Who Decides? Who Profits? Who Pays? Inside Trump's D.C. Projects
David Fahrenthold, investigative reporter for The New York Times, examines rising costs, contracts, and transparency concerns in Trump's D.C. projects.
Is The Fed About to Make Its Biggest Move Yet?
Megan Leonhardt, Senior Economics Writer at Barron's, breaks down sticky inflation, Fed policy, interest rates and what they mean for consumers.
